Open access
134
Views
0
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH
Decreased Expression of a Novel lncRNA FAM181A-AS1 is Associated with Poor Prognosis and Immune Infiltration in Lung Adenocarcinoma
Weiquan Liang1 Department of Respiratory and Critical Care Medicine, The Second People’s Hospital of Foshan (Affiliated Foshan Hospital of Southern Medical University), Foshan, 528200, People’s Republic of ChinaCorrespondence[email protected]
View further author information
, View further author information
Yiyu Lu2 Department of Oncology, The Sixth Affiliated Hospital, South China University of Technology, Foshan, 528200, People’s Republic of ChinaView further author information
, Xingxi Pan2 Department of Oncology, The Sixth Affiliated Hospital, South China University of Technology, Foshan, 528200, People’s Republic of China
https://orcid.org/0000-0003-4109-5408View further author information
Yunxiang Zeng1 Department of Respiratory and Critical Care Medicine, The Second People’s Hospital of Foshan (Affiliated Foshan Hospital of Southern Medical University), Foshan, 528200, People’s Republic of ChinaView further author information
, Weiqiang Zheng1 Department of Respiratory and Critical Care Medicine, The Second People’s Hospital of Foshan (Affiliated Foshan Hospital of Southern Medical University), Foshan, 528200, People’s Republic of ChinaView further author information
, Yiran Li1 Department of Respiratory and Critical Care Medicine, The Second People’s Hospital of Foshan (Affiliated Foshan Hospital of Southern Medical University), Foshan, 528200, People’s Republic of ChinaView further author information
, Yuanhang Nie1 Department of Respiratory and Critical Care Medicine, The Second People’s Hospital of Foshan (Affiliated Foshan Hospital of Southern Medical University), Foshan, 528200, People’s Republic of ChinaView further author information
, Dongbing Li3 ChosenMed Technology Beijing Co., Ltd, Beijing, 100853, People’s Republic of China
https://orcid.org/0000-0002-5227-9643View further author information
Dongliang Wang3 ChosenMed Technology Beijing Co., Ltd, Beijing, 100853, People’s Republic of ChinaView further author information
show all
Pages 985-998
|
Received 08 Sep 2022, Accepted 18 Nov 2022, Published online: 02 Dec 2022
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.